I Think Patients Is Going to Be a Key With Nike.

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

I wouldn't be so sure. At the moment, it's still overpriced. If we do start to see inflation, we talked our fair that if the inflation records in Europe sustained for a year, two years, we have to recalculate our goals and how that affects us. So discretionary companies, I think patients will be a key with this one. Just sticking around. Maybe I know you're a fan of putting in orders way below the target price and then forgetting about them and then at the hit. But I do honestly think this could easily come down to about $80. The reward may be bigger than the risks.

Welcome to the latest dividend talk episode. In today's show, we are comparing Nike vs Adidas. 2 global powerhouses in the sports & apparel industry. We are comparing them both from a fundamental and dividend growth portfolio.

Besides that, we're also discussing the news of the week. Shell might be changing their CEO and Starbucks just announced a new CEO. But that's just from a company point of view because inflation is really running like a virus through Europe. It's tough and we will share some of our thoughts on that.

Last but not least, eDGI also shared his "buy me a coffee" goal to meet EMF in Ireland so that they can meet each other for the first time face 2 face. If you want to support that, then feel free to buy eDGI a coffee via: www.buymeacoffee.com/edgi

As always, thank you for listening, and feel free to engage with us via the Dividend Talk Facebook group: https://www.facebook.com/groups/dividendtalk